Akari Therapeutics Plc
Pharmaceutical company · Tampa, Florida, United States · Nasdaq: AKTX
Akari Therapeutics Plc is a pharmaceutical company headquartered in Tampa, Florida, United States. Its shares trade on Nasdaq under the ticker AKTX. It has reported private securities offerings to the US SEC, most recently $1.8 million sold in a notice filed in 2026.
Akari Therapeutics at a glance
What does Akari Therapeutics do?
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $1.8 million sold (2026).
Frequently asked questions about Akari Therapeutics
Where is Akari Therapeutics headquartered?
Akari Therapeutics Plc is headquartered in Tampa, Florida, United States.
What does Akari Therapeutics do?
Akari Therapeutics Plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Akari Therapeutics a public company?
Yes. Akari Therapeutics Plc trades on Nasdaq under the ticker AKTX.
Similar companies
- TuHURA Biosciences, Inc./NVTampa, Florida, United States
- Inhibitor Therapeutics, Inc.Tampa, Florida, United States
- Biovest International IncTampa, Florida, United States
- Intezyne Technologies, Inc.Tampa, Florida, United States
- Accentia Biopharmaceuticals IncTampa, Florida, United States
- Romark Laboratories, L.C.Tampa, Florida, United States
- Kurobe Pharmaceuticals, Inc.Tampa, Florida, United States
- CTT Pharmaceutical Holdings, Inc.Tampa, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences